Skip to main content
. 2021 Mar-Apr;54(2):87–93. doi: 10.1590/0100-3984.2019.0135

Table 1.

Main clinical, pathological, and imaging features of the malignant lung lesions in our sample.

Feature N = 101
Age (years), mean ± SD (range) 66.4 ± 9.4 (41-85)
Gender (female/male), n 45/56
Smoking history (yes/no), n 84/17
History of another primary cancer (yes/no), n 33/68
Histopathology (ADC/SCC/other), n 58/27/16
T stage (1/2/3/4), n 39/47/6/9
N stage (0/1/2/3), n 53/20/20/8
M stage (0/1), n 79/22
Location (RUL/ML/RLL/LUL/LLL), n 31/3/27/20/20
Position (central/peripheral), n 6/95
Diameter (millimeters), mean ± SD (range) 32.3 ± 14.6 (10-98)

ADC, adenocarcinoma; SCC, squamous cell carcinoma; other, 7 small cell carcinomas, 5 carcinoids, 1 poorly differentiated carcinoma, 1 unspecified carcinoma, 1 large call carcinoma, 1 adenosquamous carcinoma; RUL, right upper lobe; ML, middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.